August 24, 2017
Novocure to Present at Two Upcoming Investor Conferences in September
ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced today that it will participate in two upcoming investor conferences in September. William Doyle, Novocure’s Executive Chairman, will participate in the Wells Fargo 2017 Healthcare Conference on September 6, 2017, in Boston. Mr. Doyle’s presentation will begin at 10:15 a.m. Read More
learn more
August 8, 2017
Novocure™ Announces National Reimbursement for Optune® in Austria
The decision marks Novocure’s first national coverage policy ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ: NVCR) announced today it has signed a contract with the Federation of the Austrian Social Insurance Institutions which grants reimbursement across Austria for Optune – Novocure’s Tumor Treating Fields (TTFields) delivery system –… Read More
learn more
August 2, 2017
Novocure to Present at the 2017 Wedbush PacGrow Healthcare Conference
ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced today that it will participate in the 2017 Wedbush PacGrow Healthcare Conference on August 15, 2017, in New York City. William Doyle, Novocure’s Executive Chairman, will speak on behalf of the company and address questions from analysts. Mr. Doyle’s presentation… Read More
learn more